Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Raymond Scott Maul"'
Autor:
Kim N Chi, Neil Fleshner, Vincenzo Emanuele Chiuri, Siska Van Bruwaene, Jason Hafron, Douglas G McNeel, Peter De Porre, Raymond Scott Maul, Mahesh Daksh, Xiaogang Zhong, Gary E Mason, Ronald F Tutrone
Publikováno v:
The Oncologist. 28:e309-e312
Niraparib (NIRA) is a highly selective inhibitor of poly (adenosine diphosphate-ribose) polymerase, PARP1 and PARP2, which play a role in DNA repair. The phase II QUEST study evaluated NIRA combinations in patients with metastatic castration-resistan
Autor:
Jianyu Rao, Raymond Scott Maul, Mai N. Brooks, Maryam R. Sartippour, Liping Zhang, Julian P. Whitelegge, Andrew J. Norris, Ming Lu
Publikováno v:
Cancer Research. 65:6159-6166
We recently discovered a novel gene and named it endothelial-derived gene 1 (EG-1). Previously, we have shown that the expression of EG-1 is significantly elevated in the epithelial cells of breast cancer, colorectal cancer, and prostate cancer. Here
Autor:
Robert L. Coleman, Bradley J. Monk, Roland Elmar Knoblauch, Trilok V. Parekh, Spyros Triantos, Raymond Scott Maul, Youn Choi Park, Thomas J Herzog
Publikováno v:
Journal of Clinical Oncology. 33:TPS5606-TPS5606
Autor:
Jianyu Rao, Sophia K. Apple, Mai N. Brooks, Raymond Scott Maul, Maryam R. Sartippour, Rosalio Rubio, Liping Zhang, David Seligson
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 10(10)
Purpose: We recently discovered a novel gene responsive to tumor-conditioned media: endothelial-derived gene 1 (EG-1). Its transcript has been shown to be present in epithelial cells, as well as in endothelial cells. In this study, we examined the le
Autor:
Youn C. Park, Raymond Scott Maul, Bradley J. Monk, Roland Elmar Knoblauch, Trilok V. Parekh, Robert L. Coleman, Fitzroy Dawkins, Marcela G. del Carmen, Thomas J. Herzog
Publikováno v:
Journal of Clinical Oncology. 32:TPS5612-TPS5612
TPS5606 Background: Ovarian cancer (OVC) is the eighth most common cancer among women globally, with approximately 60%–70% of cases being diagnosed at an advanced stage (III or IV). Five-year survi...
Autor:
David M. Nanus, Hans Smit, Daniel P. Petrylak, Weimin Peng, Scott T. Tagawa, Raymond Scott Maul, Justine Yang Bruce, Edwin M. Posadas, Namphuong Tran, Emerson A. Lim
Publikováno v:
Journal of Clinical Oncology. 32:5025-5025
5025 Background: Coadministration of D and AA may be beneficial due to complementary mechanisms of action. A phase 1b safety and pharmacokinetic (PK) study assessed the safety and efficacy of D + A...
Autor:
Justine Yang Bruce, Daniel P. Petrylak, Martha Gonzalez, Emerson A. Lim, Namphuong Tran, Raymond Scott Maul, Scott T. Tagawa, Edwin M. Posadas, Weimin Peng, David M. Nanus
Publikováno v:
Journal of Clinical Oncology. 32:205-205
205 Background: D and AA may have complementary mechanisms of action; coadministration may be beneficial. A phase Ib study assesses the safety of escalating doses of D + AA. Methods: Up to4 cohorts (C) of chemo-naïve mCRPC pts would receive D + AA.